Arcus Biosciences
Quarterly Financials
| Values in thousands | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|
Revenue | $160,000 | $28,000 | $26,000 | $48,000 |
Gross Profit | 160,000 | 28,000 | 26,000 | 48,000 |
EBITDA | 4,000 | -108,000 | -89,000 | -89,000 |
EBIT | 2,000 | -111,000 | -92,000 | -91,000 |
Net Income | -8,000 | -112,000 | -94,000 | -92,000 |
Net Change In Cash | 160,000 | 28,000 | 26,000 | 48,000 |
Free Cash Flow | -133,000 | -133,000 | -101,000 | 25,000 |
Cash | 248,000 | 192,000 | 150,000 | 201,000 |
Basic Shares | 106,500 | 98,400 | 91,700 | 91,400 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $258,000 | $117,000 | $112,000 | $383,000 |
Gross Profit | 258,000 | 117,000 | 112,000 | 383,000 |
EBITDA | -269,000 | -291,000 | -258,000 | 59,000 |
EBIT | -279,000 | -299,000 | -264,000 | 55,000 |
Net Income | -283,000 | -307,000 | -267,000 | 53,000 |
Net Change In Cash | 258,000 | 117,000 | 112,000 | 383,000 |
Cost of Revenue | -22,699 | |||
Free Cash Flow | -176,000 | -330,000 | 426,000 | -282,249 |
Cash | 150,000 | 127,000 | 206,000 | 147,914 |
Basic Shares | 90,100 | 74,000 | 72,000 | 73,966 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-09-30 | $0 |
2025-06-30 | $0 |
2025-03-31 | -$1.14 |
2024-12-31 | -$1.03 |
